Alkem Laboratories gets nod to transfer trade generics business to M/s. Alkem Wellness

10 Dec 2024 Evaluate

Alkem Laboratories has received approval from board of directors for transfer of the trade generics business of the Company as a going concern, on a slump sale basis, to M/s. Alkem Wellness, a wholly owned subsidiary of the Company, incorporated in India. The transaction is proposed to be effected through a business transfer agreement and will be effective on or before April 01, 2025 or such other date as may be mutually agreed between the parties, subject to customary closing conditions.

The Board of Directors of Alkem Laboratories at its meeting held on December 10, 2024 has approved the same. 

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.

Alkem Laboratories Share Price

5485.50 97.05 (1.80%)
18-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1800.30
Dr. Reddys Lab 1275.05
Cipla 1472.05
Lupin 2098.70
Zydus Lifesciences 979.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.